Indefinite Delivery Contract SPE2DR25D3044

This indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, is valued at $999,999,999 and runs through November 2026. The contract is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care.

The IDC was established through a competitive, unrestricted solicitation for the DLA Troop Support Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts. The program aims to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, the U.S. Coast Guard, designated providers, and other government agencies. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items, in addition to a separate award for a back-up supplier.